Abstract

Last week, the National Institute on Drug Abuse (NIDA) issued a press release accompanying its study, co‐sponsored with the Centers for Disease Control and Prevention (CDC), which showed that flexibilities in buprenorphine prescribing did not lead to more fatal overdoses involving buprenorphine (see story, page 4).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call